# P-Co-Li (Pulmonary Covid-19 Study)

> **NCT04782700** · NA · WITHDRAWN · sponsor: **Northwell Health**

## Conditions studied

- Covid19
- Lung Inflammation
- Hypoxemic Respiratory Failure

## Interventions

- **OTHER:** Steroid Taper (Prednisone)

## Key facts

- **NCT ID:** NCT04782700
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04-01
- **Primary completion:** 2021-06-08
- **Final completion:** 2021-06-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to recruitment we decided to withdraw the study.
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04782700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04782700, "P-Co-Li (Pulmonary Covid-19 Study)". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT04782700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*